Resveratrol protects BV2 mouse microglial cells against LPS-induced inflammatory injury by altering the miR-146a-5p/TRAF6/NF-κB axis

References

• Dionisio-Santos DA, Olschowka JA, O’Banion MK. Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease. J Neuroinflammation. 2019;16(1):74.
   PubMedGoogle Scholar
• Tiwari PC, Pal R. The potential role of neuroinflammation and transcription factors in Parkinson disease. Dialogues Clin Neurosci. 2017;19(1):71–80.
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Zhu C. Microglia in prion diseases. J Clin Invest. 2017;127(9):3230–3239.
   PubMed Web of Science ®Google Scholar
• Datta G, Colasanti A, Rabiner EA, et al. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis. Brain. 2017;140(11):2927–2938.
   PubMedGoogle Scholar
• Hawkins KE, DeMars KM, Alexander JC, et al. Targeting resolution of neuroinflammation after ischemic stroke with a lipoxin A4 analog: protective mechanisms and long-term effects on neurological recovery. Brain Behav. 2017;7(5):e00688.
   PubMed Web of Science ®Google Scholar
• Gharibi S, Moghimi B, Haghmorad D, et al. Altered expression patterns of complement factor H and miR-146a genes in acute-chronic phases in experimental autoimmune encephalomyelitis mouse. J Cell Physiol. 2019;234(11):19842.
   PubMed Web of Science ®Google Scholar
• Mao XF, Wu HY, Tang XQ, et al. Activation of GPR40 produces mechanical antiallodynia via the spinal glial interleukin-10/beta-endorphin pathway. J Neuroinflammation. 2019;16(1):84.
   PubMedGoogle Scholar
• Sayo A, Konishi H, Kobayashi M, et al. GPR34 in spinal microglia exacerbates neuropathic pain in mice. J Neuroinflammation. 2019;16(1):82.
   PubMedGoogle Scholar
• Cai Z, Hussain MD, Yan LJ. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease. Int J Neurosci. 2014;124(5):307–321.
   PubMed Web of Science ®Google Scholar
• Penas C, Navarro X. Epigenetic modifications associated to neuroinflammation and neuropathic pain after neural trauma. Front Cell Neurosci. 2018;12:158.
   PubMed Web of Science ®Google Scholar
• Zhou T, Huang YX, Song JW, et al. Thymosin beta4 inhibits microglia activation through microRNA 146a in neonatal rats following hypoxia injury. Neuroreport. 2015;26(17):1032–1038.
   PubMed Web of Science ®Google Scholar
• Finneran DJ, Nash KR. Neuroinflammation and fractalkine signaling in Alzheimer’s disease. J Neuroinflammation. 2019;16(1):30.
   PubMedGoogle Scholar
• Cherry JD, Olschowka JA, O’Banion MK. Are “resting” microglia more “m2”? Front Immunol. 2014;5:594.
   PubMed Web of Science ®Google Scholar
• Corbi G, Conti V, Davinelli S, et al. Dietary phytochemicals in neuroimmunoaging: a new therapeutic possibility for humans? Front Pharmacol. 2016;7:364.
   PubMed Web of Science ®Google Scholar
• Ghasemi F, Bagheri H, Barreto GE, et al. Effects of curcumin on microglial cells. Neurotox Res. 2019;36(1):12.
   PubMed Web of Science ®Google Scholar
• Tabrizian K, Musavi SS, Rigi M, et al. Behavioral and molecular effects of intrahippocampal infusion of auraptene, resveratrol, and curcumin on H-89-induced deficits on spatial memory acquisition and retention in Morris water maze. Hum Exp Toxicol. 2019;38:775–784.
   PubMed Web of Science ®Google Scholar
• Summerlin N, Soo E, Thakur S, et al. Resveratrol nanoformulations: challenges and opportunities. Int J Pharm. 2015;479(2):282–290.
   PubMed Web of Science ®Google Scholar
• Ahmed T, Javed S, Tariq A, et al. Resveratrol and Alzheimer’s disease: mechanistic insights. Mol Neurobiol. 2017;54(4):2622–2635.
   PubMed Web of Science ®Google Scholar
• Zhang LF, Yu XL, Ji M, et al. Resveratrol alleviates motor and cognitive deficits and neuropathology in the A53T alpha-synuclein mouse model of Parkinson’s disease. Food Funct. 2018;9(12):6414–6426.
   PubMed Web of Science ®Google Scholar
• Bhandari R, Kuhad A. Resveratrol suppresses neuroinflammation in the experimental paradigm of autism spectrum disorders. Neurochem Int. 2017;103:8–23.
   PubMed Web of Science ®Google Scholar
• Li X, Yang S, Wang L, et al. Resveratrol inhibits paclitaxel-induced neuropathic pain by the activation of PI3K/Akt and SIRT1/PGC1alpha pathway. JPR.. 2019;12:879–890.
   Web of Science ®Google Scholar
• Qi B, Shi C, Meng J, et al. Resveratrol alleviates ethanol-induced neuroinflammation in vivo and in vitro: involvement of TLR2-MyD88-NF-kappaB pathway. Int J Biochem Cell Biol. 2018;103:56–64.
   PubMed Web of Science ®Google Scholar
• Liu L, Gu H, Liu H, et al. Protective effect of resveratrol against IL-1beta-induced inflammatory response on human osteoarthritic chondrocytes partly via the TLR4/MyD88/NF-kappaB signaling pathway: an “in vitro study”. IJMS. 2014;15(4):6925–6940.
   Google Scholar
• Jakus PB, Kalman N, Antus C, et al. TRAF6 is functional in inhibition of TLR4-mediated NF-κB activation by resveratrol. J Nutr Biochem. 2013;24(5):819–823.
   PubMed Web of Science ®Google Scholar
• Gorska K, Winssinger N. Rapid miRNA imaging in cells using fluorogenic templated Staudinger reaction between PNA-based probes. Methods Mol Biol. 2014;1050:179–192.
   PubMedGoogle Scholar
• Selbach M, Schwanhausser B, Thierfelder N, et al. Widespread changes in protein synthesis induced by microRNAs. Nature. 2008;455(7209):58–63.
   PubMed Web of Science ®Google Scholar
• Freilich RW, Woodbury ME, Ikezu T. Integrated expression profiles of mRNA and miRNA in polarized primary murine microglia. PLoS One. 2013;8(11):e79416.
   PubMed Web of Science ®Google Scholar
• Venuti A, Musarra-Pizzo M, Pennisi R, et al. HSV-1\EGFP stimulates miR-146a expression in a NF-κB-dependent manner in monocytic THP-1 cells. Sci Rep. 2019;9(1):5157.
   PubMedGoogle Scholar
• Paik S, Choe JH, Choi GE, et al. Rg6, a rare ginsenoside, inhibits systemic inflammation through the induction of interleukin-10 and microRNA-146a. Sci Rep. 2019;9(1):4342.
   PubMed Web of Science ®Google Scholar
• Juknat A, Gao F, Coppola G, et al. miRNA expression profiles and molecular networks in resting and LPS-activated BV-2 microglia-Effect of cannabinoids. PLoS One. 2019;14(2):e0212039.
   PubMed Web of Science ®Google Scholar
• Lu Y, Cao DL, Jiang BC, et al. MicroRNA-146a-5p attenuates neuropathic pain via suppressing TRAF6 signaling in the spinal cord. Brain Behav Immun. 2015;49:119–129.
   PubMed Web of Science ®Google Scholar
• Liu XS, Chopp M, Pan WL, et al. MicroRNA-146a promotes oligodendrogenesis in stroke. Mol Neurobiol. 2017;54(1):227–237.
   PubMed Web of Science ®Google Scholar
• Wang X, Ha T, Liu L, et al. Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury. Cardiovasc Res. 2013;97(3):432–442.
   PubMed Web of Science ®Google Scholar
• Aronica E, Fluiter K, Iyer A, et al. Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur J Neurosci. 2010;31(6):1100–1107.
   PubMed Web of Science ®Google Scholar
• Gaudet AD, Fonken LK, Watkins LR, et al. MicroRNAs: roles in regulating neuroinflammation. Neuroscientist. 2018;24(3):221–245.
   PubMed Web of Science ®Google Scholar
• Tili E, Michaille JJ. Promiscuous effects of some phenolic natural products on inflammation at least in part arise from their ability to modulate the expression of global regulators, namely microRNAs. Molecules. 2016;21(9):1263.
   Web of Science ®Google Scholar
• Gandy KAO, Zhang J, Nagarkatti P, et al. Resveratrol (3, 5, 4'-trihydroxy-trans-stilbene) attenuates a mouse model of multiple sclerosis by altering the miR-124/sphingosine kinase 1 axis in encephalitogenic T cells in the brain. J Neuroimmune Pharmacol. 2019;14(3):462.
   PubMed Web of Science ®Google Scholar
• Ma C, Wang Y, Shen A, et al. Resveratrol upregulates SOCS1 production by lipopolysaccharide-stimulated RAW264.7 macrophages by inhibiting miR-155. Int J Mol Med. 2017;39(1):231–237.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lu Y, Ong’achwa MJ, et al. Resveratrol inhibits the TGF-beta1-induced proliferation of cardiac fibroblasts and collagen secretion by downregulating miR-17 in rat. Biomed Res Int. 2018;2018:1.
   Google Scholar
• Jin H, Zhang H, Ma T, et al. Resveratrol protects murine chondrogenic ATDC5 cells against LPS-induced inflammatory injury through up-regulating MiR-146b. Cell Physiol Biochem. 2018;47(3):972–980.
   PubMedGoogle Scholar
• Wang X, Zhang Y. Resveratrol alleviates LPS-induced injury in human keratinocyte cell line HaCaT by up-regulation of miR-17. Biochem Biophys Res Commun. 2018;501(1):106–112.
   PubMed Web of Science ®Google Scholar
• Bigagli E, Cinci L, Paccosi S, et al. Nutritionally relevant concentrations of resveratrol and hydroxytyrosol mitigate oxidative burst of human granulocytes and monocytes and the production of pro-inflammatory mediators in LPS-stimulated RAW 264.7 macrophages. Int Immunopharmacol. 2017;43:147–155.
   PubMed Web of Science ®Google Scholar
• Li L, Sun Q, Li Y, et al. Overexpression of SIRT1 induced by resveratrol and inhibitor of miR-204 suppresses activation and proliferation of microglia. J Mol Neurosci. 2015;56(4):858–867.
   PubMed Web of Science ®Google Scholar
• Hui B, Zhang L, Zhou Q, et al. Pristimerin inhibits LPS-triggered neurotoxicity in BV-2 microglia cells through modulating IRAK1/TRAF6/TAK1-mediated NF-kappaB and AP-1 signaling pathways in vitro. Neurotox Res. 2018;33(2):268–283.
   PubMed Web of Science ®Google Scholar
• Lei JR, Tu XK, Wang Y, et al. Resveratrol downregulates the TLR4 signaling pathway to reduce brain damage in a rat model of focal cerebral ischemia. Exp Ther Med. 2019;17(4):3215–3221.
   PubMed Web of Science ®Google Scholar
• Tao L, Ding Q, Gao C, et al. Resveratrol attenuates neuropathic pain through balancing pro-inflammatory and anti-inflammatory cytokines release in mice. Int Immunopharmacol. 2016;34:165–172.
   PubMed Web of Science ®Google Scholar
• Cui Y, Wang Y, Zhao D, et al. Loganin prevents BV-2 microglia cells from Aβ1-42 -induced inflammation via regulating TLR4/TRAF6/NF-κB axis. Cell Biol Int. 2018;42(12):1632–1642.
   PubMed Web of Science ®Google Scholar
• He X, Zheng Y, Liu S, et al. MiR-146a protects small intestine against ischemia/reperfusion injury by down-regulating TLR4/TRAF6/NF-kappaB pathway. J Cell Physiol. 2018;233(3):2476–2488.
   PubMed Web of Science ®Google Scholar
• Lim R, Barker G, Lappas M. The TLR2 ligand FSL-1 and the TLR5 ligand Flagellin mediate pro-inflammatory and pro-labour response via MyD88/TRAF6/NF-kappaB-dependent signalling. Am J Reprod Immunol. 2014;71(5):401–417.
   PubMed Web of Science ®Google Scholar
• Chen H, Jin Y, Liao N, et al. MicroRNA-mediated inflammatory responses induced by Cryptococcus neoformans are dependent on the NF-kappaB pathway in human monocytes. Int J Mol Med. 2017;39(6):1525–1532.
   PubMed Web of Science ®Google Scholar
• Jiang M, Li X, Yu X, et al. Oral administration of resveratrol alleviates osteoarthritis pathology in C57BL/6J mice model induced by a high-fat diet. Mediators Inflamm. 2017;2017:1.
   Google Scholar
• Wang G, Hu Z, Fu Q, et al. Resveratrol mitigates lipopolysaccharide-mediated acute inflammation in rats by inhibiting the TLR4/NF-kappaBp65/MAPKs signaling cascade. Sci Rep. 2017;7(1):45006.
   PubMedGoogle Scholar
• Taganov KD, Boldin MP, Chang KJ, et al. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006;103(33):12481–12486.
   PubMed Web of Science ®Google Scholar
• Chen L, Dong R, Lu Y, et al. MicroRNA-146a protects against cognitive decline induced by surgical trauma by suppressing hippocampal neuroinflammation in mice. Brain Behav Immun. 2019;78:188–201.
   PubMed Web of Science ®Google Scholar
• Deng M, Du G, Zhao J, et al. miR-146a negatively regulates the induction of proinflammatory cytokines in response to Japanese encephalitis virus infection in microglial cells. Arch Virol. 2017;162(6):1495–1505.
   PubMed Web of Science ®Google Scholar
• Cunha C, Gomes C, Vaz AR, et al. Exploring new inflammatory biomarkers and pathways during LPS-induced M1 polarization. Mediators Inflamm. 2016;2016:1.
   Google Scholar
• Lukiw WJ. NF-small ka, CyrillicB-regulated micro RNAs (miRNAs) in primary human brain cells. Exp Neurol. 2012;235(2):484–490.
   PubMed Web of Science ®Google Scholar
• Du L, Rong H, Cheng Y, et al. Identification of microRNAs dysregulated in CD14 gene silencing RAW264.7 macrophage cells. Inflammation. 2014;37(1):287–294.
   PubMed Web of Science ®Google Scholar
• Sheedy FJ, Palsson-McDermott E, Hennessy EJ, et al. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol. 2010;11(2):141–147.
   PubMed Web of Science ®Google Scholar
• Pan Y, Wang J, Xue Y, et al. GSKJ4 protects mice against early sepsis via reducing proinflammatory factors and up-regulating MiR-146a. Front Immunol. 2018;9:2272.
   PubMed Web of Science ®Google Scholar
• Lambert KA, Roff AN, Panganiban RP, et al. MicroRNA-146a is induced by inflammatory stimuli in airway epithelial cells and augments the anti-inflammatory effects of glucocorticoids. PLoS One. 2018;13(10):e0205434.
   PubMed Web of Science ®Google Scholar
• Kubota K, Nakano M, Kobayashi E, et al. An enriched environment prevents diabetes-induced cognitive impairment in rats by enhancing exosomal miR-146a secretion from endogenous bone marrow-derived mesenchymal stem cells. PLoS One. 2018;13(9):e0204252.
   PubMed Web of Science ®Google Scholar
• Sharma N, Verma R, Kumawat KL, et al. miR-146a suppresses cellular immune response during Japanese encephalitis virus JaOArS982 strain infection in human microglial cells. J Neuroinflammation. 2015;12(1):30.
   PubMedGoogle Scholar
• Li X, Gibson G, Kim JS, et al. MicroRNA-146a is linked to pain-related pathophysiology of osteoarthritis. Gene. 2011;480(1–2):34–41.
   PubMed Web of Science ®Google Scholar
• Yin Y, Li F, Shi J, et al. MiR-146a regulates inflammatory infiltration by macrophages in Polymyositis/Dermatomyositis by targeting TRAF6 and affecting IL-17/ICAM-1 pathway. Cell Physiol Biochem. 2016;40(3–4):486–498.
   PubMedGoogle Scholar
• Zu Y, Yang Y, Zhu J, et al. MiR-146a suppresses hepatocellular carcinoma by downregulating TRAF6. Am J Cancer Res. 2016;6(11):2502–2513.
   PubMed Web of Science ®Google Scholar
• Monticelli S, Ansel KM, Xiao C, et al. MicroRNA profiling of the murine hematopoietic system. Genome Biol. 2005;6(8):R71.
   PubMed Web of Science ®Google Scholar
• He H, Jazdzewski K, Li W, et al. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA.. 2005;102(52):19075–19080.
   PubMed Web of Science ®Google Scholar